Cervical cancer, Cisplatin, Hyperthermia, Radiotherapy, Therapeutic ratio
dx.doi.org/10.1080/02656730110083738, hdl.handle.net/1765/66199
International Journal of Hyperthermia
Department of Gynaecology & Obstetrics

van der Zee, J, Koper, P.C.M, Lutgens, L.C, & Burger, C.W. (2002). Point-counterpoint: What is the optimal trial design to test hyperthermia for carcinoma of the cervix? Point: Addition of hyperthermia or cisplatin to radiotherapy for patients with cervical cancer; Two promising combinations - No definite conclusions. International Journal of Hyperthermia (Vol. 18, pp. 19–24). doi:10.1080/02656730110083738